Global generic pharmaceutical giant Teva recently released its generic version of Zetia (ezetimibe) in 10mg tablets to address total and low-density lipoprotein (LDL) blood cholesterol levels for U.S. patients, company officials announced from Jerusalem headquarters. Read More »

Daiichi Sankyo Inc. will take the helm on handling U.S. commercialization of the FDA-approved RoxyBond (oxycodone hydrochloride) oral-use medication manufactured by Inspirion Delivery Sciences LLC, the companies announced recently from their respective New Jersey hubs. Read More »

CVS Health has released an article about making it easier for patients to prevent and manage chronic disease. Read More »

Express Scripts has released its 2016 Drug Trend Report for the commercial market. Read More »

The U.S. Supreme Court issued a 9-0 ruling today that will have the effect of speeding the process for biosimilars going to market. Read More »

Mutual recommitment to a partnership between Pfizer and two U.S. foundations has successfully ensured continued access to Pfizer’s Sayana Press contraceptive for women in the world’s poorest nations. Read More »

AstraZeneca and TerSera Therapeutics LLC (TerSera) have entered a agreement that gives TerSera the commercial rights to Zoladex in the United States and Canada. Read More »

Endo International plc recently announced that one of its operating companies, Endo Pharmaceuticals Inc. based in Malvern, Pennsylvania, is voluntarily recalling one lot of Edex (alprostadil) for injection because the company detected a defect in the crimp caps used in the manufacture of the subject product lot. Read More »

DelMar Pharmaceuticals recently hosted a Key Opinion Leader forum at the Lotte New York Palace Hotel in New York City, highlighting its novel treatment for patients suffering from glioblastoma multiforme. Read More »

Six finalists of the Sandoz HACk presented their ideals to a panel of judges at WIRE Health in London. Read More »

CVS Health recently released a report highlighting the health care needs of an aging population, noting that Americans are living longer than ever before. Read More »

Protagonist Therapeutics Inc., announced May 30 that they have formed a worldwide license and collaboration with Janssen Biotech Inc. Read More »

Innovus Pharmaceuticals Inc. is signing an exclusive license and distribution agreement for commercialization of Zestra and Zestra Glide with Luminarie Pty Ltd. throughout Australia, New Zealand and the Philippines. Read More »

Sierra Oncology has been granted a selection patent for its Chk1 inhibitor, SRA737 by the U.S. Patent and Trademark Office. Read More »

According to the Technavio’s latest market study, the North American pharmaceutical packaging market is expected to grow through 2021. Read More »

Direct Relief is working with Pfizer to provide up to a million doses of life-saving Naloxone to community health centers, free clinics, public health departments and other non-profits nationwide in response to the opioid epidemic. Read More »

ScriptSave recently announced that it has partnered with Physicians Mutual to provide discounts on prescription medication to Physicians Mutual customers through its ScriptSave WellRx program. Read More »

Hematogenix Laboratory Services, a company that provides integrated pathology services for drug development, recently announced that that Merck & Co. Inc. has included it as one of the national reference laboratories for U.S. Food and Drug Administration (FDA)-approved PD-L1 companion diagnostic assay PD-L1 IHC 22C3 pharmDx for Keytruda. Read More »

Otsuka Pharmaceutical has entered into a licensing agreement that gives it exclusive rights to develop and commercialize Teva Pharmaceutical Industries' migraine prevention drug fremanezumab in Japan. Read More »

Allergan PLC, a global biopharmaceutical company, recently concluded its $2.9 billion acquisition of LifeCell Corp., a business that develops regenerative medicine. Read More »